April 3, 2008, Westford, MA--Five presentations at the 28th American Society for Laser Medicine and Surgery (ASLMS) annual meeting in Kissimee, FL this week will showcase Cynosure's aesthetic laser technology and products, including the Smartlipo LaserBodySculpting Workstation.
David J. Goldberg, M.D., J.D., Director of Skin Laser & Surgery Specialists of NY/NJ and Clinical Professor of Dermatology at the Mount Sinai School of Medicine in New York, will present a study that examines the benefits of the Smartlipo LaserBodySculpting workstation, Cynosure's groundbreaking flagship product for the minimally invasive removal of concentrated areas of unwanted fat. Findings of the study support the role that Smartlipo plays in the tightening of loose skin through collagen remodeling.
Bruce Katz, M.D., Clinical Professor, Mt. Sinai School of Medicine, and Director of the Juva Skin and Laser Center in New York, will present data from a study that demonstrates a low complication rate among more than 500 patients treated with Smartlipo.
"Over the past two years, we have found Smartlipo to be safe and effective with less than 1% complication rates, none of which were serious and all of which resolved over time," said Dr. Katz, who also will speak about Cynosure's laser lipolysis technology as part of a four-hour course on skin rejuvenation. "Smartlipo has become an essential and a comprehensive tool for treating unwanted fat and tightening skin."
Dr. Emil Tanghetti of the Center for Dermatology and Laser Surgery (Sacramento, CA) and Dr. Jennifer R. Lloyd of the Lloyd Dermatology Center (Youngstown, OH) will present findings from a 24-patient study on their use of the Affirm Anti-Aging Workstation for the treatment of acne scars. Their research will compare the clinical benefits of Affirm's Multiplex technology, which enables the rapid sequential emission of two wavelengths, 1320 nm and 1440 nm, from the same optical fiber, to the benefits of a 1320 nm wavelength alone.
Brian S. Biesman of the Nashville Centre for Laser and Facial Surgery (Nashville, TN) will discuss findings from a prospective clinical study that evaluates the benefits of the Affirm workstation from the standpoint of patient downtime and discomfort.
Ranella Hirsch, M.D. and Christine Dierickx, M.D. will present their evaluation of Cynosure's Cynergy Multiplex Laser for the treatment of various vascular lesions. Dr. Hirsch is Assistant Clinical Professor of Dermatology at the Boston University School of Medicine and the President of the American Society of Cosmetic Dermatology and Aesthetic Surgery. Dr. Dierickx is a Visiting Scientist at the Harvard Medical School and Director of the Skin and Laser Center in Belgium.
"The scope of the data being presented at ASLMS provides further evidence of the clinical benefits of our technology for some of the aesthetic industry's fastest-growing applications," said Cynosure President and CEO Michael Davin. "We are privileged to have some of the industry's leading experts presenting clinical research on our technology at this conference."